Rapid reversal of no-reflow using Abciximab after coronary device intervention

David Rawitscher, Thomas N. Levin, Ian Cohen, Ted Feldman*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

51 Scopus citations

Fingerprint

Dive into the research topics of 'Rapid reversal of no-reflow using Abciximab after coronary device intervention'. Together they form a unique fingerprint.

Medicine & Life Sciences